Label: MOXIFLOXACIN PF- moxifloxacin pf injection, solution

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated May 8, 2018

If you are a consumer or patient please visit this version.

  • STORAGE AND HANDLING

    Store at 20° to 25° C (68° to 77° F)

    Close
  • Vial Label
  • INGREDIENTS AND APPEARANCE
    MOXIFLOXACIN PF 
    moxifloxacin pf injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70261-511
    Route of Administration INTRAOCULAR
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE (UNII: B8956S8609) (MOXIFLOXACIN - UNII:U188XYD42P) MOXIFLOXACIN 5 mg  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 8 mg  in 1 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:70261-511-01 1 mL in 1 VIAL, GLASS; Type 0: Not a Combination Product 01/01/2018
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    unapproved drug other 01/01/2018
    Labeler - ImprimisRx NJ (931390178)
    Registrant - ImprimisRx NJ (931390178)
    Establishment
    Name Address ID/FEI Business Operations
    Imprimis Pharmaceuticals 080431967 manufacture(70261-511)
    Close